Posts written by madridre

Doctors warn of long-term health effects COVID-19 has on its survivors

August 11, 2020

Dr. Anoop M. Nambiar, MD gives interview with News4SA about the long term affects of COVID-19. SAN ANTONIO – Doctors are now studying the long-term effects of COVID-19 on those who have recovered. We spoke with two patients who are undergoing rehabilitation after hospital stays. "I have to do breathing exercises that the doctor asked [...]

Blood clot issue found in young COVID-19 patients at University Hospital

May 5, 2020

Clots in arms, legs, lungs, reported at University Hospital… SAN ANTONIO – University hospital is seeing a troubling trend when it comes to young people hospitalized with coronavirus. Even without having a predisposition for stroke, younger patients are still at risk for developing a deadly blood clot. So far, no one with coronavirus has suffered a […]

Five therapies for COVID-19 tried, tested at University Hospital

April 24, 2020

Doctors at University Hospital have launched an aggressive testing campaign of new drugs and treatments they hope will help them create a cocktail for COVID-19 cures in the future.   Diego Maselli, MD According to Dr. Diego Maselli, medical director of respiratory therapy at University Hospital, the repertoire for hospitalized treatment includes five drug approaches. [...]

Local conference organized by alumnus shares expertise about point-of-care ultrasound to physicians

March 5, 2020

Dr. Nilam Soni, alumnus of the M.S. in Clinical Investigation & Translational Science program, and professor of medicine at UT Health San Antonio helped organize the 10th annual Point-of-care Ultrasound Workshop held Feb. 14 to 15 in downtown San Antonio. Dr. Soni, is also the director of Point-of-Care Ultrasound Training of VHA SimLEARN, co-director of Medical […]

Meet the 2019-2020 CHEST President: Stephanie Levine, MD, FCCP

October 21, 2019

Stephanie Levine, MD, FCCP, is an expert in lung transplantation and pulmonary and critical care issues in pregnancy and women’s lung health. She is a Professor of Medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of Texas Health Science Center in San Antonio, Texas; the Program Director of the […]

Congratulations to Pulmonary Faculty for contributing to the American Thoracic Society Documents

October 10, 2019

Dr. Antonio Anzueto and Dr. Marcos I. Restrepo from the Department of Medicine, Pulmonary Division, co-authored a paper recently published by the American Thoracic Society documents Diagnosis and Treatment of Adults with Community-acquired Pneumonia.

Congratulations to Dr. Diego Maselli and Dr. Antonio Anzueto for co-authoring an article published in CHEST.

August 21, 2019

Clinical Epidemiology of COPD Insights From 10 Years of the COPDGene Study The Genetic Epidemiology of COPD (COPDGene) study is a noninterventional, multicenter, longitudinal analysis of > 10,000 subjects, including smokers with a $ 10 pack-year history with and without COPD and healthy never smokers. The goal was to characterize disease-related phenotypes and explore associations […]

Test for Deadly Lung Disease Is Used for First Time in Texas – Anoop Nambiar, MD

June 11, 2019

A UT Health San Antonio lung specialist is the first in Texas to use a new genomic test to better and less invasively diagnose a patient with idiopathic pulmonary fibrosis (IPF), a serious, chronic, progressive and scarring lung disease with an average survival time of less than five years after diagnosis.......Read more>>>> click image above [...]

Wear The Gown: Managing the rare disease of cystic fibrosis

May 28, 2019

SAN ANTONIO — There are 70,000 people in the world with cystic fibrosis. 30,000 of them are here in the U.S. In this Wear The Gown, we take you into the only "CF" clinic in San Antonio that takes care of patients from birth, all the way into adulthood. "Cystic fibrosis is a genetic disease [...]

Medical News Today: Can we halt cellular aging? New drug combo shows promise

February 28, 2019

The story below features research Anoop Nambiar, M.D., M.S., on a new class of drugs called senolytics that were studied in relation to idiopathic pulmonary fibrosis. Dr. Nambiar is a professor of medicine and founding director of the Interstitial Lung Disease Program at UT Health San Antonio. Two other faculty members are mentioned in the [...]